Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025The World Journal of Men s HealthOpen Access

Testosterone Replacement Therapy in Hypogonadal Men with a Prostate Cancer Diagnosis: A British Society for Sexual Medicine Consensus Statement

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMarie Alexandra EdisonMKMichael KirbyGHGeoffrey Hackett

Discussion

Loading...

Member takes

Overview

Consensus statement assesses oncological safety and quality of life improvements in hypogonadal men with prostate cancer, indicating multifaceted clinical considerations.

Key Points

  • Testosterone replacement therapy shows potential benefits in hypogonadal men recovering from prostate cancer.
  • The consensus reviews oncological safety, highlighting concerns of recurrence alongside symptom management.
  • Clinical scenarios of TRT use include active surveillance, post-radical prostatectomy, and post-radiotherapy.
  • Emphasizes the need for a multidisciplinary approach to treatment decision-making in this patient population.

Cite This Study

Edison et al. (2025) studied this question.

synapsesocial.com/papers/68c240deb210217d6479d30ehttps://doi.org/10.5534/wjmh.250086
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies2025
  2. 2Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism2026
  3. 3How does Testosterone Therapy Impact Quality of Life and Cancer Recurrence Rates in High-Risk Prostate Cancer Survivors? : A Systematic Review2025
  4. 4Association Between Testosterone Replacement Therapy and Prostatic Disorders in Elderly Hypogonadal Men2025
  5. 5Clinical Benefits of Testosterone Replacement Therapy in Men: Evidence from A Narrative Review2025 · 2 citations